| SFDA Approved Use |
Methylprednisolone is indicated to treat any condition in which rapid and intense corticosteroid effect is
required such as: 1. Dermatological disease Severe erythema multiforme (Stevens-Johnson syndrome) 2. Allergic states Bronchial asthma Angioneurotic oedema Anaphylaxis 3. Gastro-intestinal diseases Ulcerative colitis Crohn"s disease 4. Respiratory diseases Aspiration of gastric contents Fulminating or disseminated tuberculosis (with appropriate anti-tuberculous chemotherapy) 5. Neurological disorders Cerebral oedema secondary to cerebral tumour Acute exacerbations of multiple sclerosis superimposed on a relapsing-remitting background 6. Miscellaneous T.B. meningitis (with appropriate antituberculous chemotherapy) |
|---|
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Thu 25 Jun 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Government websites use the protocol. HTTPS for encryption and security.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.